HealthQuill Cancer
More than 35 million people may have cancer in 2050 — an increase of 77% from 20 million new cases in 2022, according to a WHO report.
Drugs Health Pharma

Cancer cases set to rise by 77% to 35 million in 2050: WHO global survey

More than 35 million people may have cancer in 2050 — an increase of 77% from 20 million new cases in 2022, according.

Read More
Merck & Co., will acquire Harpoon Therapeutics, Inc., for $680 million to expand its cancer drug portfolio — a transaction expected to close by the middle of this year.
Drugs Health Pharma

Merck to buy Harpoon for $680 million to step up cancer portfolio

HQ Team January 8, 2024: Merck & Co., will acquire Harpoon Therapeutics, Inc., for $680 million to expand its cancer drug portfolio —.

Read More
Moderna Inc., expects to break even in 2026 as it aims to drive profits by “disciplined investment” and organic sales growth.
Drugs Health Pharma

Moderna expects to break even in 2026, says CEO Stéphane Bancel

HQ Team January 5, 2023: Moderna Inc., expects to break even in 2026 as it aims to drive profits by “disciplined investment” and.

Read More
Teenagers are using e-cigarettes at a rate higher than adults, and in England, the numbers have tripled in the past three years, according to the World Health Organization.
Drugs Health Pharma

Teenagers smoking e-cigarettes at a faster rate than adults: WHO

HQ Team December 15, 2023: Teenagers are using e-cigarettes at a rate higher than adults, and in England, the numbers have tripled in.

Read More
Pfizer is expected to close the $43 billion acquisition of Seagen by Thursday as the company announced restructuring its business and management.
Drugs Health Pharma

Pfizer revamps organisation as $43 billion Seagen deal comes to close

HQ Team December 13, 2023: Pfizer is expected to close the $43 billion acquisition of Seagen by Thursday as the company announced restructuring.

Read More
2023: Bristol Myers Squib will pay a total of $8.4 billion to SystImmune Inc., the US arm of Chinese drugmaker Sichuan Biokin Pharmaceutical Co., to jointly develop and market a cancer drug outside China.
Drugs Health Pharma

Bristol Myer to pay China’s drugmaker Sichuan $8.4b to develop cancer drug

HQ Team December 12, 2023: Bristol Myers Squib will pay a total of $8.4 billion to SystImmune Inc., the US arm of Chinese.

Read More
Opinion: HPV, cervical cancer, women and vaccination
Drugs Health Pharma

Opinion: HPV, cervical cancer, women and vaccination

By K. Leelamoni December 12, 2023: The Human Papilloma Virus (HPV) is the name of a group of viruses of 200 known viruses..

Read More
AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to acquire ImmunoGen, Inc., for $10.1 billion. Image Credit: AbbVie
Drugs Health Pharma

AbbVie to buy Immunogen for $10.1b to expand solid tumour market

HQ Team November 30, 2023: AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to.

Read More
India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to treat leukaemia and cancer of the lymphatic system.
Drugs Health Pharma

ImmunoACT gets nod for leukaemia, lymphoma cancer therapy in India

HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to.

Read More
Eli Lilly and Company announced its experimental drug for treating severe Crohn's disease met secondary targets in efficacy and safety.
Drugs Health Pharma

Eli Lilly late-stage trial drug for Crohn’s disease meets testing goals

HQ Team October 13, 2023: Eli Lilly and Company announced its experimental drug for treating severe Crohn’s disease met secondary targets in efficacy.

Read More